Others

Items 8001-8050 of 13505

Page
per page
Set Descending Direction
Catalog No.
Product Name
Application
Product Information
Citations
  1. Drug Impurity

    Salmeterol impurity 10 is a known impurity of the long-acting β2 adrenergic agonist Salmeterol. This compound serves as a reference standard for analytical methods and is crucial for the quality control of pharmaceutical formulations containing Salmeterol. Its characterization is essential for ensuring the purity and efficacy of respiratory medications, particularly in the treatment of asthma and chronic obstructive pulmonary disease (COPD).
  2. Drug Impurity

    Trazodone Impurity 3 Hydrochloride is a known impurity of Trazodone Hydrochloride. This compound serves as a critical reference standard for the identification and quantification of impurities in pharmaceutical formulations. It is primarily utilized in quality control and analytical studies to ensure compliance with regulatory guidelines in drug manufacturing.
  3. Drug Impurity

    Gabapentin acid impurity 3 is a chemical impurity associated with the synthesis of Gabapentin acid. This compound is primarily used for quality control and analytical purposes in the pharmaceutical industry. Its presence and quantification are critical for assessing the purity of Gabapentin acid in drug formulations.
  4. Drug Impurity

    Levothyroxine impurity 3 is a known impurity associated with Levothyroxine, a synthetic thyroid hormone. This compound is essential for research focused on the characterization of drug impurities, stability studies, and quality control of pharmaceutical formulations. It aids in understanding the impact of impurities on the efficacy and safety of thyroid medications.
  5. Losartan Impurity

    Losartan Impurity 15 is a chemical entity related to Losartan, specifically characterized by the presence of an azido group. This impurity serves as an important analytical reference for the characterization and quality assessment of Losartan synthesis. It is commonly utilized in pharmaceutical research to study the stability and degradation pathways of Losartan, as well as to ensure compliance with regulatory standards for drug purity.
  6. Drug Impurity

    Afatinib impurity 58 is a chemical reagent that serves as an impurity associated with the drug Afatinib. This compound may be utilized in analytical chemistry for quality control and stability studies of Afatinib formulations. Its presence is critical for ensuring the purity and safety of pharmaceutical products during research and development.
  7. Drug Impurity

    Tenofovir impurity 20 is a chemical impurity associated with Tenofovir, an antiretroviral medication utilized in the treatment and prevention of HIV. This impurity is relevant for quality control and regulatory compliance in pharmaceutical research and development. It aids in the assessment of Tenofovir's purity and can be used in stability studies to ensure the integrity of therapeutic formulations.
  8. Drug Impurity

    Clobazam impurity 1 is a characterized impurity associated with the anxiolytic agent Clobazam. This compound is essential for analytical purposes in quality control and method development for Clobazam formulations. Its presence and quantification can aid in assessing the purity and safety of pharmaceutical products containing Clobazam.
  9. Drug Impurity

    Beclometasone dipropionate impurity 10 is a chemical impurity associated with the corticosteroid Beclometasone dipropionate. This impurity is relevant for drug quality assessments and stability studies in pharmaceutical research. It plays a critical role in ensuring the safety, efficacy, and regulatory compliance of corticosteroid formulations. Researchers can utilize this compound in purity testing and characterization of Beclometasone dipropionate.
  10. Drug Impurity

    Prednisolone Impurity 6 is an identified impurity of the corticosteroid prednisolone. This compound is essential for understanding the purity profiles and characterization of prednisolone in pharmaceutical applications. It aids researchers in assessing the potential impacts of impurities on drug efficacy and safety, supporting quality control and compliance in drug development processes.
  11. Drug Intermediate

    D-Pyroaspartic acid is a synthetic intermediate primarily utilized in pharmaceutical synthesis. Its unique structure allows it to participate in the formation of various bioactive compounds, making it instrumental in the development of novel therapeutic agents. This compound serves as a valuable building block in chemical research and drug discovery applications.
  12. Drug Impurity

    Ibrutinib Impurity 1 is a chemical impurity associated with the pharmacological compound Ibrutinib, an inhibitor of Bruton's tyrosine kinase (BTK). This impurity is relevant for analytical chemistry and quality control applications in pharmaceutical development to ensure the purity and safety of Ibrutinib formulations. It serves as an important reference standard for assessing the effects and stability of drug formulations containing Ibrutinib.
  13. Drug Impurity

    Famotidine impurity 3 is a known impurity associated with Famotidine. It serves as a critical analytical standard for assessing the purity and quality of Famotidine formulations. This compound is essential for regulatory compliance and quality control in pharmaceutical research and development, particularly in studies examining drug stability and degradation profiles.
  14. Drug Impurity

    Telmisartan impurity 13 is a chemical impurity associated with the antihypertensive agent Telmisartan. This compound can be utilized in quality control measures and analytical studies for drug formulation, ensuring the purity and efficacy of Telmisartan in pharmacological applications. Its characterization is crucial for compliance with regulatory standards in pharmaceutical development.
  15. Drug Impurity

    Tamsulosin impurity 18 is a known impurity of the selective alpha-1 adrenergic antagonist, Tamsulosin, primarily utilized in the treatment of benign prostatic hyperplasia. This impurity is essential for quality control and analytical studies in pharmaceutical development, aiding in the assessment of Tamsulosin's purity and stability. Researchers can employ Tamsulosin impurity 18 for method validation, impurity profiling, and ensuring compliance with regulatory standards.
  16. Drug Intermediate

    N-Fmoc-ethylenediamine hydrobromide is a crucial reagent for organic synthesis, primarily serving as a protective group for amino functionalities. This compound enhances the efficiency and selectivity of peptide and amino compound synthesis in biochemical research. Its properties make it an essential building block in various chemical reactions, facilitating the preparation of complex molecular structures.
  17. Drug Impurity

    Adapalene impurity 1 is a known impurity associated with the topical retinoid Adapalene, primarily utilized for its role in dermatological treatments. Its presence necessitates monitoring during pharmaceutical formulation development to ensure product quality and efficacy. This reagent is integral for analytical studies focused on the characterization and quantification of drug impurities in pharmaceutical research.
  18. Drug Impurity

    Duloxetine impurity 7 is a characterized impurity related to the pharmaceutical agent Duloxetine, which acts as a selective serotonin and norepinephrine reuptake inhibitor (SSNRI). This impurity is relevant for analytical chemistry and quality control in the production of Duloxetine, supporting the evaluation of purity and compliance with regulatory standards. Its study can provide insights into the synthesis and metabolic pathways of Duloxetine, aiding in the development of safer and more effective therapeutics.
  19. Drug Impurity

    Levofloxacin impurity 1, also known as Levofloxacin impurity G, is a known impurity related to the antibiotic Levofloxacin. This compound serves as a valuable reference standard for analytical testing and quality control in pharmaceutical research and development. Its characterization can assist in the assessment of the purity and stability of Levofloxacin and facilitate investigations into potential drug interactions and efficacy.
  20. Drug Impurity

    Dehydro glycopyrrolate bromide is identified as an impurity associated with the synthesis of glycopyrrolate. As a chemical research reagent, it is primarily utilized for quality control and validation within pharmaceutical development. Analysis of this impurity aids in understanding the stability and purity of glycopyrrolate formulations, thereby supporting regulatory compliance and product safety assessments.
  21. Drug Impurity

    Hydroxychloroquine impurity 3 is a known impurity associated with Hydroxychloroquine. This chemical entity is utilized primarily in analytical chemistry to assess the purity of Hydroxychloroquine formulations. Its presence may influence the pharmacological properties of the main compound and is important for quality control in pharmaceutical research and development.
  22. Drug Impurity

    Quetiapine impurity 22 is a chemical impurity associated with the antipsychotic medication Quetiapine. This impurity can be utilized in pharmaceutical research to evaluate the purity and stability of Quetiapine formulations, as well as to study potential metabolic byproducts. Its presence may impact the efficacy and safety profile of the drug, making it relevant for quality control in drug development and regulatory compliance studies.
  23. Drug Impurity

    Acebutolol impurity 4 is a chemical impurity associated with the antihypertensive agent Acebutolol. This compound is employed in pharmaceutical research to establish the purity and quality of Acebutolol formulations. Its identification and characterization are essential for regulatory compliance and to ensure the efficacy and safety of the final pharmaceutical product.
  24. Drug Impurity

    Betamethasone dipropionate impurity 7 is identified as an impurity associated with Betamethasone dipropionate. Its characterization is essential for ensuring the purity and quality of pharmaceutical formulations containing Betamethasone dipropionate. This compound serves as a reference standard for analytical techniques such as HPLC and mass spectrometry, facilitating method development and validation in quality control laboratories.
  25. Drug Impurity

    Afatinib impurity 31 is a defined impurity related to the tyrosine kinase inhibitor Afatinib, which primarily targets EGFR (epidermal growth factor receptor). This compound serves as a reference standard for quality control in the synthesis and formulation of Afatinib, facilitating the assessment of drug purity in research and development settings. Its characterization is essential for ensuring compliance with regulatory standards in pharmaceutical applications.
  26. Drug Impurity

    Azilsartan impurity 19, also known as N-Ethyl azilsartan medoxomil, is a drug impurity associated with Azilsartan. This compound serves as a reference standard for analytical chemistry applications, particularly in the quality control and validation of Azilsartan formulations. Its presence and characterization are essential for ensuring the safety and efficacy of pharmaceutical products containing Azilsartan.
  27. Drug Impurity

    Ethambutol impurity 2 is a known impurity associated with the antitubercular agent Ethambutol. This compound serves as a critical reference standard in the quality control of Ethambutol formulations, aiding in the assessment of drug purity and the identification of potential contaminants. Its presence can significantly influence pharmacokinetic and therapeutic profiles, making it valuable for analytical studies and regulatory compliance in pharmaceutical research.
  28. Drug Impurity

    Bumetanide impurity 2 is a recognized impurity associated with the diuretic agent Bumetanide. This compound serves as a critical reference standard for the assessment of purity in pharmaceutical formulations. Its analysis is essential for ensuring the safety and efficacy of drug products containing Bumetanide. Researchers can utilize this impurity in method development and validation studies within quality control laboratories.
  29. Drug Impurity

    Diclofenac impurity 2 is a drug impurity associated with the pharmaceutical compound Diclofenac. It is primarily utilized in the pharmaceutical research and development sectors to ensure the safety and efficacy of drug formulations. The identification and quantification of this impurity are critical for compliance with regulatory standards and for understanding the drug's overall pharmacological profile.
  30. Drug Impurity

    Clopidogrel impurity 7 bromide is a recognized impurity associated with Clopidogrel bromide, serving as an important component in drug quality control. This compound is utilized in analytical chemistry and pharmaceutical development to assess the purity and stability of clopidogrel formulations. Its identification and characterization are crucial for ensuring compliance with regulatory standards in drug manufacturing.
  31. Lipid

    16:0 Tempo PC is a phosphocholine derivative featuring a TEMPO moiety, specifically (2,2,6,6-tetramethylpiperidin-1-yl)oxyl. This compound serves as a spin label in lipid membrane research, facilitating studies in electron paramagnetic resonance spectroscopy. Its applications extend to functioning as a paramagnetic contrast agent in NMR, as well as serving as an oxygen-sensitive probe in various biological systems, making it a valuable tool for examining lipid interactions and dynamics.
  32. Lipid

    (E/Z)-C2 Ceramide is a bioactive sphingolipid that plays a critical role in cellular signaling pathways. It is involved in various biological processes including apoptosis, cell differentiation, and inflammation. This compound serves as a valuable tool for research applications in cell biology, neurobiology, and cancer studies, aiding in the understanding of lipid metabolism and cell membrane dynamics.
  33. Biochemical Reagent

    ADH-353 is a biochemical reagent that effectively inhibits amyloid-beta (Aβ) fibrillation and alleviates Aβ-induced cytotoxicity in SH-SY5Y and N2a neuronal cell lines. This compound is valuable for research focused on Alzheimer's disease pathogenesis and the development of potential therapeutic strategies.
  34. Lipid

    3-(Stearoyloxy)propane-1,2-diyl diacetate is a triglyceride that serves as a lipid surrogate in biochemical research. Its structure allows for investigations into lipid metabolism and membrane interactions. This compound is primarily utilized in studies related to energy storage, lipid signaling pathways, and the biophysical properties of lipid bilayers.
  35. Lipid

    24:1 CPE (d18/24:1) is a phosphosphingolipid that serves as a key structural component in cellular membranes. It plays a critical role in lipid signaling and cellular communication, making it valuable for research in cell biology and membrane biophysics. This reagent is particularly useful in studies involving lipid metabolism and the exploration of sphingolipid-related pathways.
  36. Lipid

    Monolinolein is a monoacylglycerol that primarily targets lipid metabolism pathways. It exhibits significant properties as an emulsifier and can influence the bioavailability of lipophilic compounds in various biological systems. Additionally, monolinolein is utilized in research applications focused on lipid formulation, drug delivery systems, and studying cellular lipid interactions.
  37. Lipid

    1,2-Dilinolein is an acylglycerol that serves as an important structural lipid. It exhibits significant biological activity by participating in lipid metabolism and influencing membrane dynamics. This compound is pertinent in research focused on cellular signaling pathways, lipid bilayer studies, and understanding the role of fatty acids in health and disease.
  38. Lipid

    2,3-Dihydroxypropyl nonadecanoate is an acylglycerol that acts as a lipid compound. It exhibits significant biological activity in lipid metabolism and can be utilized in various biochemical studies aimed at understanding lipid biochemistry and metabolism. This reagent serves as a valuable tool for research involving lipid signaling pathways and metabolism in cellular systems.
  39. Biochemical Reagent

    W2476 is a biochemical reagent that modulates the thioredoxin-interacting protein signaling pathway. By promoting competitive binding of the forkhead box O1 transcription factor (FOXO1), W2476 enhances insulin secretion and mitigates β-cell dysfunction in diabetic mouse models. This compound serves as a valuable tool for research into diabetes and metabolic disorders.
  40. Lipid

    MSDH is an enzyme that plays a crucial role in the biosynthesis of Coenzyme Q10, essential for cellular energy production. By facilitating the synthesis of this vital cofactor, MSDH contributes to the regulation of mitochondrial function and energy metabolism. Its activity is of significant interest in studies of metabolic disorders and conditions associated with Coenzyme Q10 deficiency.
  41. Lipid

    βGlcCer is a glycosphingolipid that serves as a crucial component of cellular membranes. It is involved in various biological processes, including cell signaling, immune response, and cellular recognition. Research applications for βGlcCer encompass studies on cellular dynamics, lipid metabolism, and its role in diseases related to glycosphingolipid metabolism, making it essential for investigations in cell biology and biochemistry.
  42. Lipid

    18:0 Aminoethyl Phosphatidylcholine is a site-specific phosphocholine derivative. It serves as a key component in lipid biochemistry, particularly for membrane biophysics studies. This reagent is useful in investigating lipid-protein interactions and understanding the role of phosphatidylcholine in cellular processes. Its unique properties make it suitable for applications in drug delivery systems and biophysical characterization of membrane structures.
  43. Metal-organic Framework

    1,3-Bis(1-methyl-1H-benzo[d]imidazol-2-yl)benzene is a ligand designed for the formation of metal-organic frameworks (MOFs). This compound exhibits strong coordination properties with metal ions, facilitating the synthesis of highly structured porous materials. Its unique structural features make it suitable for various research applications, including gas storage, separation processes, and catalysis studies.
  44. FTY72 Derivative

    FTY720-C2 is a derivative of FTY72 that targets neurotrophic factors to enhance their expression. It promotes the production of brain-derived neurotrophic factor (BDNF) and glial cell-derived neurotrophic factor (GDNF) in models of multiple system atrophy (MSA) while maintaining immune function. FTY720-C2 has been shown to improve motor dysfunction and reduce insoluble alpha-synuclein (αSyn) levels in MSA mouse models. Additionally, it is capable of penetrating the blood-brain barrier, making it a valuable tool for neurological research.
  45. Lipid

    24:0 CPE (d18:1/24:0) is a phosphosphingolipid that serves as a key component in cellular membranes. It plays a crucial role in cell signaling and lipid metabolism, making it valuable for research in lipid biology and membrane dynamics. This reagent is essential for studying the structural and functional properties of sphingolipids in various biological contexts.
  46. Metal-organic Framework

    meso-Tetrakis(4-thiophenephenyl)porphyrin is a porphyrin compound that serves as a ligand in the formation of metal-organic frameworks (MOFs). This compound exhibits unique coordination properties, allowing for the encapsulation of metal ions and the synthesis of diverse MOF structures. It is commonly utilized in research applications involving gas storage, catalysis, and the development of advanced materials for electronic devices.
  47. Metal-organic Framework

    1,1'-Bis(4-(dimethylamino)phenyl)-[4,4'-bipyridine]-1,1'-diium (dichloride) serves as a metal-organic framework (MOF) that facilitates the formation of porous materials with tunable properties. Its structural characteristics allow for the incorporation of various metal ions, enhancing its potential in gas adsorption and catalysis. This compound is widely utilized in the study of material science, specifically in the development of advanced materials for applications including environmental remediation and energy storage.
  48. Metal-organic Framework

    [2,2′-Bipyridine]-4,4′-dibutanoic acid functions as a building block in the synthesis of metal-organic frameworks (MOFs). This compound exhibits significant coordination properties, making it suitable for the construction of hybrid structures with enhanced stability and functionality. Its unique molecular architecture finds applications in gas storage, separation technologies, and catalysis research, contributing to advancements in materials science and nanotechnology.
  49. Metal-organic Framework

    4,4',4''-(Benzene-1,3,5-triyltris(azanediyl))tribenzoic acid serves as a ligand in the construction of metal-organic frameworks (MOFs). It exhibits significant potential for applications in gas storage, separation processes, and catalysis. Its robust structural properties enhance the stability and efficiency of MOFs in various chemical research applications.
  50. Metal-organic Framework

    2'-(Phenyldiazenyl)-[1,1':4',1"-terphenyl]-4,4"-dicarboxylic acid serves as a precursor for the synthesis of metal-organic frameworks (MOFs). This compound exhibits significant potential for the development of functional materials with applications in gas storage, catalysis, and separation processes. Researchers can utilize this dicarboxylic acid to explore its structural properties and enhance the performance of MOFs in various chemical processes.

Items 8001-8050 of 13505

Page
per page
Set Descending Direction